Skip to main content
Premium Trial:

Request an Annual Quote

Sequencing Startup Stratos Genomics Raises $4M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Stratos Genomics today announced that it has raised $4 million through a Series A financing led by Fisk Ventures and including Stratos Group LLC.

The Seattle-based firm said that it would use the proceeds to continue developing its ultra-low-cost nucleic acid sequencing method for whole-genome analysis and molecular diagnostic applications. Stratos Genomics, which is a spinoff of Stratos Group, has developed a single-molecule sequencing method called "sequencing by expansion."

"The Stratos Genomics technology has the potential to revolutionize personalized medicine and bring genome sequencing technology to all," Stephen Rose, Managing Director of Fisk Ventures, said. "If our goals are realized, Stratos Genomics will have a huge impact on life sciences."

Following the investment, Rose has joined the board of directors of Stratos Genomics.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.